Physician profile
Fernando Quezada
NPI 1851411797
$1,962.35
in general payments reported to CMS, 2019-2025
14 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $147 · 2023: $157 · 2024: $1,329 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $607.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,060.84 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $298.42 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $169.77 | 2021-2024 | |
| Lilly USA, LLC | $95.67 | 2021-2024 | Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $75.96 | 2023-2025 | Shingrix, Arexvy |
| Astellas Pharma US INC | $61.56 | 2024 | Veozah |
| Exact Sciences Corporation | $60.09 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $24.78 | 2024 | Freestyle Libre 3 |
| Genentech USA, INC. | $24.59 | 2021 | |
| Edwards Lifesciences Corporation | $23.46 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.03 | 2022 | |
| Pfizer INC. | $16.47 | 2025 | |
| Idorsia Pharmaceuticals US INC | $13.71 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Quezada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.